A new study reveals the critical role of the WRKY-B transcription factor in regulating lateral branch development in tomato ...

The flow battery is one of the more interesting ideas for grid energy storage – after all, how many batteries combine electron current with fluid current? If you’re interested in trying your ...

Texas lawmakers have approved a healthcare bill that paves the way for immigrant and undocumented medical graduates to practice medicine in the state.

Omeros’ lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application under review by FDA for the treatment of hematopoietic ...

MBL (mannose-binding lectin), a pattern recognition molecule circulating in complex with MASPs (MBL-associated serine proteases), activates the lectin complement pathway and facilitates thrombin ...

Omeros’ lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application under review by FDA for the treatment of hematopoietic ...

Most Appropriate Pathway to Revascularize Using Angiography-Derived Fractional Flow Reserve (Quantitative Flow Ratio) to Guide Percutaneous Coronary Intervention (PCI) ...

C3G and IC-MPGN cause protein deposits that reduce kidney function. Treatment helps lower or prevent kidney damage.

In the classical pathway it is activated by antibodies, so it is an antigen driven pathway. In the lectin pathway, carbohydrate epitopes on microbes are recognized.

Omeros’ lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application pending before FDA for the treatment of hematopoietic ...

Objective The complement system plays a central role in the pathogenesis of Systemic Lupus Erythematosus (SLE), but most studies have focused on the classical pathway. Ficolin-3 is the main initiator ...

Researchers in China have identified a series of engineering strategies to bring aqueous sulfur-based redox flow batteries closer to commercial production. Improving catalyst design, ion-selective ...